NemaLife receives funding to develop a neurotherapeutic discovery platform
NemaLife receives funding to develop a neurotherapeutic discovery platform using next-generation psychedelic compounds. LUBBOCK, TX, USA,...
NemaLife receives funding to develop a neurotherapeutic discovery platform
NemaLife has received a Rising Star Award from BioNTX
NemaLife CTO receives the prestigious REDI award from the National Institute on Aging
BioSpace Article - Worms: They’re a Lot Like Us, and that’s Good for Drug Development
Collaborative effort led by Marian Walhout spotlights worms as model for personalized medicine
Google Interviews the NemaLife Team
US House passes legislation to end FDA animal testing mandate
Motif FoodWorks Announces Strategic Investment in NemaLife, Inc.
DEA registered NemaLife Inc. to work with Schedule 1 substances